the market?
Arena Pharmaceuticals, Inc.
NASDAQ: ARNA
8.30
0.24
(2.99%)
| Today's Open | $8.04 |
|---|---|
| Previous Close | $8.06 |
| Daily Range | $8.01 - $8.36 |
| 52-Week Range | $5.86 - $13.50 |
| Market Cap | $1.8B |
| P/E Ratio | -22.39 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 6,433,131 |
| Average Daily Volume | 5,273,699 |
| Current FY EPS | -$0.12 |
How do you think ARNA
will perform against the market?
Top ARNA Bull/Bear Pitches
weightlossman (0)
Submitted
August 31, 2010
Arena Pharma's (ARNA) Lorcaserin will eventually be approved. It's side effects are benign. Research has shown that it does not cause pulmonary hypertension nor heart-valve damage. Arena has comple … More
DarthMaul09 (< 20)
Submitted
July 23, 2010
Even if a new med is found to be clinically useful and has made it past the FDA, then it needs to get past insurance companies and be marketed adequately to physicians, who still remember Fen/Fen and … More
News & Commentary
3 Pipeline Obesity Treatments You Should Watch
In the past year, two approved obesity drugs put the massive obesity market within reach of investors. Here are three treatments under development that could have even bigger consequences.The Surprising Link Between ADHD and Obesity
This disorder in childhood could put your adult health at risk.The 9 Most Obese Countries in the World
Obesity trends are on the rise in these nine countries. See what's being done to counteract this potentially worrisome trend.Weight Loss Isn't Just for Looking Good Anymore
Medical benefits are helping obesity drugs get coverage. Will the government help?Sector
Healthcare
Industry
Drugs
Arena Pharmaceuticals, Inc. (ARNA) Description
A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Website: http://www.arenapharm.com/
CEO Rating by Glassdoor
More details for Arena Pharmaceuticals Jobs
Arena Pharmaceuticals reviews from employees
